Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


suck pdf from google scholar
PDF vom PMID34932807  :  Publisher
PDF vom PMID34932807

suck abstract from ncbi

Nephropedia Template TP Text

Twit Text FOAVip

Twit Text #

English Wikipedia

  • Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Center #MMPMID34932807
  • Carosi G; Morelli V; Del Sindaco G; Serban AL; Cremaschi A; Frigerio S; Rodari G; Profka E; Indirli R; Mungari R; Resi V; Orsi E; Ferrante E; Dolci A; Giavoli C; Arosio M; Mantovani G
  • J Clin Endocrinol Metab 2021[Mar]; 106 (3): e1354-e1361 PMID34932807show ga
  • CONTEXT: Coronavirus disease 2019 (COVID-19) represents a global health emergency, and infected patients with chronic diseases often present with a severe impairment. Adrenal insufficiency (AI) is supposed to be associated with an increased infection risk, which could trigger an adrenal crisis. OBJECTIVE: Our primary aim was to evaluate the incidence of COVID-19 symptoms and complications in AI patients. DESIGN AND SETTING: We conducted a retrospective case-control study. All patients were on active follow-up and lived in Lombardy, Italy, one of the most affected areas. PATIENTS: We enrolled 279 patients with primary and secondary AI and 112 controls (patients with benign pituitary lesions without hormonal alterations). All AI patients had been previously trained to modify their replacement therapy on stress doses. INTERVENTION: By administering a standardized questionnaire by phone, we collected data on COVID-19 suggestive symptoms and consequences. RESULTS: In February through April 2020, the prevalence of symptomatic patients (complaining at least 1 symptom of viral infection) was similar between the 2 groups (24% in AI and 22.3% in controls, P = 0.79). Highly suggestive COVID-19 symptoms (at least 2 including fever and/or cough) also occurred equally in AI and controls (12.5% in both groups). No patient required hospitalization and no adrenal crisis was reported. Few nasopharyngeal swabs were performed (n = 12), as indicated by sanitary regulations, limiting conclusions on the exact infection rate (2 positive results in AI and none in controls, P = 0.52). CONCLUSIONS: AI patients who are adequately treated and trained seem to display the same incidence of COVID-19-suggestive symptoms and disease severity as controls.
  • |Adrenal Insufficiency/*complications/drug therapy/immunology[MESH]
  • |Adult[MESH]
  • |Aged[MESH]
  • |COVID-19/diagnosis/*epidemiology/immunology[MESH]
  • |Case-Control Studies[MESH]
  • |Cortisone/administration & dosage[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Hydrocortisone/administration & dosage[MESH]
  • |Incidence[MESH]
  • |Italy/epidemiology[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Prevalence[MESH]
  • |Retrospective Studies[MESH]
  • |Risk Factors[MESH]
  • |SARS-CoV-2/isolation & purification[MESH]
  • |Severity of Illness Index[MESH]
  • |Tertiary Care Centers/statistics & numerical data[MESH]

  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    e1354 3.106 2021